| Document And Entity Information | 9 Months Ended | |
| Aug. 31, 2014 | Oct. 09, 2014 | |
| Document Information [Line Items] | ' | ' |
| Entity Registrant Name | 'TWINLAB CONSOLIDATED HOLDINGS, INC. | ' |
| Entity Central Index Key | '0001590695 | ' |
| Current Fiscal Year End Date | '--11-30 | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Trading Symbol | 'TLCC | ' |
| Entity Common Stock, Shares Outstanding | ' | 220,000,000 |
| Document Type | '10-Q | ' |
| Amendment Flag | 'false | ' |
| Document Period End Date | 31-Aug-14 | ' |
| Document Fiscal Period Focus | 'Q3 | ' |
| Document Fiscal Year Focus | '2014 | ' |
| BALANCE SHEETS (USD $) | Aug. 31, 2014 | Nov. 30, 2013 |
| Current assets: | ' | ' |
| Cash | $95 | $890 |
| Prepaid expenses | 0 | 4,600 |
| Total current assets | 95 | 5,490 |
| Total assets | 95 | 5,490 |
| Current liabilities: | ' | ' |
| Accounts payable | 180,422 | 5,700 |
| Total current liabilities | 180,422 | 5,700 |
| Long term liabilities: | ' | ' |
| Accrued interest payable - related party | 319 | 3 |
| Line of credit - related party | 7,000 | 7,000 |
| Total long term liabilities | 7,319 | 7,003 |
| Total liabilities | 187,741 | 12,703 |
| Stockholders' deficit: | ' | ' |
| Preferred stock, $0.001 par value, 500,000,000 shares authorized, no shares issued and outstanding as of August 31, 2014 and November 30, 2013, respectively | 0 | 0 |
| Common stock, $0.001 par value, 5,000,000,000 shares authorized, 220,000,000 and 200,000,000 shares issued and outstanding as of August 31, 2014 and November 30, 2013, respectively | 220,000 | 200,000 |
| Additional paid in capital | -176,000 | -196,000 |
| Accumulated deficit | -231,646 | -11,213 |
| Total stockholders' deficit | -187,646 | -7,213 |
| Total liabilities and stockholders' deficit | $95 | $5,490 |
| BALANCE SHEETS (Parenthetical) (USD $) | Aug. 31, 2014 | Nov. 30, 2013 |
| Preferred stock, par value | $0.00 | $0.00 |
| Preferred Stock, Shares Authorized | 500,000,000 | 500,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 |
| Preferred Stock, Shares Outstanding | 0 | 0 |
| Common stock, par value | $0.00 | $0.00 |
| Common Stock, Shares Authorized | 5,000,000,000 | 5,000,000,000 |
| Common Stock, Shares, Issued | 220,000,000 | 200,000,000 |
| Common Stock, Shares, Outstanding | 220,000,000 | 200,000,000 |
| STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 9 Months Ended |
| Aug. 31, 2014 | Aug. 31, 2014 | |
| Revenue | $0 | $0 |
| Operating expenses: | ' | ' |
| General and administrative | 7,031 | 9,107 |
| Professional fees | 152,247 | 209,610 |
| Research and development | 0 | 1,400 |
| Total operating expenses | 159,278 | 220,117 |
| Other expense: | ' | ' |
| Interest expense - related party | -106 | -316 |
| Total other expense | -106 | -316 |
| Net loss | ($159,384) | ($220,433) |
| Weighted average number of common shares outstanding - basic and diluted (in shares) | 220,000,000 | 208,978,102 |
| Net loss per share - basic and diluted (in dollars per share) | $0 | $0 |
| STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended |
| Aug. 31, 2014 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ' |
| Net loss | ($220,433) |
| Changes in operating assets and liabilities: | ' |
| Decrease in prepaid expenses | 4,600 |
| Increase in accounts payable | 174,722 |
| Increase in accrued interest payable - related party | 316 |
| Net cash used in operating activities | -40,795 |
| CASH FLOWS FROM FINANCING ACTIVITIES | ' |
| Proceeds from the sale of common stock | 40,000 |
| Net cash provided by financing activities | 40,000 |
| NET CHANGE IN CASH | -795 |
| CASH AT BEGINNING OF PERIOD | 890 |
| CASH AT END OF PERIOD | $95 |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
| Aug. 31, 2014 | |
| Accounting Policies [Abstract] | ' |
| Significant Accounting Policies [Text Block] | ' |
| NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
| Basis of presentation | |
| The interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. | |
| These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements of the Company for the year ended November 30, 2013 and notes thereto included in the Company’s S-1 registration statement and all amendments. The Company follows the same accounting policies in the preparation of interim reports. | |
| Results of operations for the interim period are not indicative of annual results. | |
| Organization | |
| The Company was incorporated on October 24, 2013 (Date of Inception) under the laws of the State of Nevada, as Mirror Me, Inc., therefore comparative periods are not shown in the accompanying statements of operations and cash flows. On August 7, 2014, the Company amended its articles of incorporation and changed its name to Twinlab Consolidated Holdings, Inc. | |
| As of August 31, 2014, the Company had not commenced significant operations. However, as discussed in Note 5, on September 16, 2014, the Company merged with an operating company. | |
| Nature of operations | |
| As a result of the reverse merger discussed in Note 5, the Company intends to manufacture and market high-quality, science-based nutritional supplements, and also provide health and wellness information. | |
| Products include vitamins, minerals, specialty supplements and sports nutrition products primarily under the Twinlab® brand name (including the Twinlab Fuel family of sports nutrition products); diet and energy products under the Metabolife® brand name; a line of products that promote joint health under the Trigosamine® brand name; and a full line of herbal teas under the Alvita® brand name. These products are sold primarily through health and natural food stores, national and regional drug store chains, supermarkets, and mass market retailers. | |
| Earnings per share | |
| Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. | |
| Use of estimates | |
| The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates. | |
| Recent accounting pronouncements | |
| The Company has elected early adoption of Accounting Standard Update (ASU) 2014-10, Topic 915, Development Stage Entities, Elimination of Certain Financial Reporting Requirements. ASU 2014-10 removes all incremental financial reporting requirements for development stage entities, including, but not limited to, inception-to-date financial information included on the statements of operations, statements of stockholders’ equity (deficit) and statements of cash flows. As a result of the Company’s early adoption, all references to the Company as a development stage entity have been removed. The adoption of this pronouncement has no impact on the Company’s financial position, results of operations or liquidity. | |
| GOING CONCERN | 9 Months Ended |
| Aug. 31, 2014 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
| Liquidity Disclosure [Policy Text Block] | ' |
| NOTE 2 – GOING CONCERN | |
| The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As noted above, the Company has not yet generated revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring start up costs and expenses. As a result, the Company incurred a net loss for the nine months ended August 31, 2014 of $220,433. In addition, the Company’s activities since inception have been financially sustained through debt and equity financing. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. | |
| The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital from the sale of common stock and, ultimately, the achievement of significant operating revenues. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. | |
| LINE OF CREDIT - RELATED PARTY | 9 Months Ended |
| Aug. 31, 2014 | |
| Related Party Transactions [Abstract] | ' |
| Related Party Transactions Disclosure [Text Block] | ' |
| NOTE 3 – LINE OF CREDIT – RELATED PARTY | |
| On November 27, 2013, the Company executed a revolving credit line with a related party for up to $20,000. The unsecured line of credit bears interest at 6% per annum with principal and interest due on November 27, 2015. As of August 31, 2014, an amount of $7,000 has been used for general corporate purposes with a remaining balance of $13,000 available. As of August 31, 2014, the balance of accrued interest was $319. | |
| Interest expense for the nine months ended August 31, 2014 was $316. | |
| STOCKHOLDERS' EQUITY | 9 Months Ended |
| Aug. 31, 2014 | |
| Equity [Abstract] | ' |
| Stockholders' Equity Note Disclosure [Text Block] | ' |
| NOTE 4 – STOCKHOLDERS’ EQUITY | |
| The Company is authorized to issue 5,000,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), and 500,000,000 shares of preferred stock, par value $0.001 per share (“Preferred Stock”). | |
| On August 28, 2014, the Company effectuated a 50 to 1 forward split of its issued and unissued common shares as of September 9, 2014, the record date. All shares and amounts have been adjusted for the stock split. | |
| Common Stock | |
| On May 1, 2014, the Company issued 20,000,000 shares of Common Stock at a price of $0.002 per share for cash of $40,000. | |
| During the nine months ended August 31, 2014, there have been no other issuances of Common Stock. | |
| SUBSEQUENT EVENTS | 9 Months Ended |
| Aug. 31, 2014 | |
| Subsequent Events [Abstract] | ' |
| Subsequent Events [Text Block] | ' |
| NOTE 5 – SUBSEQUENT EVENTS | |
| Reverse Merger | |
| On September 4, 2014, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, TCC MERGER CO (“Sub Co”), a Delaware corporation and wholly-owned subsidiary of the Company, and Twinlab Consolidation Corporation (“TCC”), a Delaware corporation. The Merger Agreement provides for the merger of Sub Co with and into TCC (the “Merger”), with TCC surviving the Merger as a wholly-owned subsidiary of the Company. | |
| Common Stock Repurchased | |
| On September 16, 2014, the Company repurchased 199,995,000 shares of Common Stock in exchange for $8,000. Additionally, the selling stockholder forgave debt of $7,000 and accrued interest of approximately $320 and agreed to resign as an officer and director of the Company. | |
| On September 16, 2014, the Company completed the Merger, pursuant to the Merger Agreement, by and among the Company, Sub Co and TCC, whereby TCC became a wholly-owned subsidiary of the Company. Upon completion of the Merger, all holders of shares of TCC common stock received, for each one share of TCC common stock held by them, one share of Common Stock and the holder of one share of TCC preferred stock received 26,870,132 shares of Common Stock. | |
| Change of Fiscal Year | |
| The Company changed its fiscal year to December 31st. | |
| Series A and Series B Warrants Granted and Common Stock Put Agreement | |
| The Company issued a Series A Warrant (the “First Warrant”) to Capstone Financial Group, Inc. (“Capstone”), effective as of September 30, 2014. Pursuant to the First Warrant, Capstone has the right to purchase up to 52,631,579 shares of Common Stock at an exercise price of $0.76 per share. The First Warrant is exercisable from October 1, 2014 through October 31, 2017. The First Warrant provides for equitable adjustments in the event of a stock split, stock dividend, reclassification, consolidation or merger. The Company has agreed with Capstone that if the Company issues a security (i) exercisable or exchangeable for or (ii) convertible into shares of Common Stock at a date after October 1, 2014 and such security provides for anti-dilution protection, the shares of Common Stock issuable under the First Warrant shall enjoy the same anti-dilution protection as that first issued security. | |
| The Company also issued a Series B Warrant (the “Second Warrant”) to Capstone, effective as of September 30, 2014. Pursuant to the Second Warrant, Capstone has the right to purchase up to 22,368,421 shares of Common Stock at an exercise price of $0.76 per share. The Second Warrant is exercisable from October 1, 2014 through October 31, 2017 but only to the extent and in the same proportions as exercises by Capstone of the First Warrant. The Second Warrant provides for equitable adjustments in the event of a stock split, stock dividend, reclassification, consolidation or merger. The Company has agreed with Capstone that if the Company issues a security (i) exercisable or exchangeable for or (ii) convertible into shares of Common Stock at a date after October 1, 2014 and such security provides for anti-dilution protection, the shares of Common Stock issuable under the Second Warrant shall enjoy the same anti-dilution protection as that first issued security. | |
| The Company and Capstone entered into a Common Stock Put Agreement, dated as of September 30, 2014 (the “Put Agreement”). Pursuant to the Put Agreement, Capstone indicated its intent to exercise the First Warrant at a rate of no less than 1,461,988 shares of Common Stock (the “Minimum Amount”) per month over the term of the First Warrant (the “Minimum Rate”). In the event that Capstone does not exercise the First Warrant by November 15, 2014 or any subsequent Periodic Exercise Date (as defined in the Put Agreement) such that as of the applicable Exercise Date, Capstone’s cumulative purchases of Common Stock pursuant to the First Warrant has not been at a rate that is equal to or in excess of the Minimum Rate, then the Company has the right to notify Capstone not earlier than 30 days and not later than 40 days after the applicable Exercise Date of the Company’s exercise of its put rights under the Put Agreement (the “Put Notice”). Upon receipt of the Put Notice, Capstone is required to exercise the First Warrant to (i) purchase the Minimum Amount by a date identified in the Put Notice that is no earlier than 10 days after and no later than 30 days after the date of the Put Notice (the “Put Date”), or if Capstone has previously exercised the First Warrant to purchase shares in excess of the Minimum Rate, then such lesser amount of Common Stock as would, if purchased as of the applicable Exercise Date, have made Capstone’s purchases of Common Stock pursuant to the First Warrant as of such Exercise Date equal to the Minimum Rate (the “Initial Mandatory Purchase”) and (ii) purchase by a date that is no later than each subsequent Periodic Exercise Date an amount of Common Stock such that as of each such Periodic Exercise Date, Capstone’s cumulative purchases of Common Stock pursuant to the First Warrant through that date has been at a rate that is no less than the Minimum Rate (the “Periodic Mandatory Purchases”). Following delivery of the Put Notice by the Company, Capstone’s failure to make the Initial Mandatory Purchase by the Put Date shall be an “Event of Default”. Following the delivery of the Put Notice by the Company, Capstone’s failure to make when due any Periodic Mandatory Purchase is a breach of the Put Agreement, and if such breach is not timely cured by Capstone, such uncured breach shall be deemed an Event of Default. Upon the occurrence of an Event of Default as described above, (i) Capstone’s right to purchase all shares of Common Stock remaining unpurchased under the First Warrant is converted into an obligation, accelerated and immediately due and (ii) the Second Warrant immediately terminates as to any shares of Common Stock remaining exercisable under the Second Warrant. In the event the Company invokes its right pursuant to the Put Notice to require Capstone to exercise the First Warrant, the purchase price per share of Common Stock thereunder is $0.775 per share. In the event that the Company converts and accelerates Capstone’s obligations to purchase the shares of Common Stock remaining unexercised under the First Warrant, Capstone has the right to surrender issued and outstanding shares of Common Stock to the Company to be credited towards Capstone’s obligations, with such surrendered shares valued at $0.76 per share of Common Stock. | |
| Registration Rights Agreement | |
| The Company and Capstone entered into a Registration Rights Agreement, dated as of September 30, 2014 (the “Registration Agreement”). Pursuant to the Registration Agreement, Capstone can require the Company to register the shares of Common Stock acquired upon exercise of the First Warrant and the Second Warrant at such time as the Company is eligible to register securities on a Registration Statement on Form S-3 and thereafter file additional registration statements if requested by Capstone on a quarterly basis. The Registration Agreement contains terms and conditions customary for the grant of registration rights. | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
| Aug. 31, 2014 | |
| Accounting Policies [Abstract] | ' |
| Basis of Accounting, Policy [Policy Text Block] | ' |
| Basis of presentation | |
| The interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. | |
| These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with the financial statements of the Company for the year ended November 30, 2013 and notes thereto included in the Company’s S-1 registration statement and all amendments. The Company follows the same accounting policies in the preparation of interim reports. | |
| Results of operations for the interim period are not indicative of annual results. | |
| Organization [Policy Text Block] | ' |
| Organization | |
| The Company was incorporated on October 24, 2013 (Date of Inception) under the laws of the State of Nevada, as Mirror Me, Inc., therefore comparative periods are not shown in the accompanying statements of operations and cash flows. On August 7, 2014, the Company amended its articles of incorporation and changed its name to Twinlab Consolidated Holdings, Inc. | |
| As of August 31, 2014, the Company had not commenced significant operations. However, as discussed in Note 5, on September 16, 2014, the Company merged with an operating company. | |
| Nature Of Operations [Policy Text Block] | ' |
| Nature of operations | |
| As a result of the reverse merger discussed in Note 5, the Company intends to manufacture and market high-quality, science-based nutritional supplements, and also provide health and wellness information. | |
| Products include vitamins, minerals, specialty supplements and sports nutrition products primarily under the Twinlab® brand name (including the Twinlab Fuel family of sports nutrition products); diet and energy products under the Metabolife® brand name; a line of products that promote joint health under the Trigosamine® brand name; and a full line of herbal teas under the Alvita® brand name. These products are sold primarily through health and natural food stores, national and regional drug store chains, supermarkets, and mass market retailers. | |
| Earnings Per Share, Policy [Policy Text Block] | ' |
| Earnings per share | |
| Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. | |
| Use of Estimates, Policy [Policy Text Block] | ' |
| Use of estimates | |
| The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates. | |
| New Accounting Pronouncements, Policy [Policy Text Block] | ' |
| Recent accounting pronouncements | |
| The Company has elected early adoption of Accounting Standard Update (ASU) 2014-10, Topic 915, Development Stage Entities, Elimination of Certain Financial Reporting Requirements. ASU 2014-10 removes all incremental financial reporting requirements for development stage entities, including, but not limited to, inception-to-date financial information included on the statements of operations, statements of stockholders’ equity (deficit) and statements of cash flows. As a result of the Company’s early adoption, all references to the Company as a development stage entity have been removed. The adoption of this pronouncement has no impact on the Company’s financial position, results of operations or liquidity. | |
| GOING CONCERN (Details Textual) (USD $) | 3 Months Ended | 9 Months Ended |
| Aug. 31, 2014 | Aug. 31, 2014 | |
| Going Concern [Line Items] | ' | ' |
| Net Income (Loss) Attributable to Parent | ($159,384) | ($220,433) |
| LINE OF CREDIT - RELATED PARTY (Details Textual) (USD $) | 3 Months Ended | 9 Months Ended | ||
| Aug. 31, 2014 | Aug. 31, 2014 | Nov. 30, 2013 | Nov. 27, 2013 | |
| Line of Credit Facility [Line Items] | ' | ' | ' | ' |
| Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | $20,000 |
| Line of Credit Facility, Interest Rate During Period | ' | 6.00% | ' | ' |
| Line of Credit Facility, Expiration Date | ' | 27-Nov-15 | ' | ' |
| Long-term Line of Credit | 7,000 | 7,000 | 7,000 | ' |
| Line of Credit Facility, Remaining Borrowing Capacity | 13,000 | 13,000 | ' | ' |
| Interest Payable | 319 | 319 | 3 | ' |
| Interest Expense, Related Party | $106 | $316 | ' | ' |
| STOCKHOLDERS' EQUITY (Details Textual) (USD $) | 1 Months Ended | 9 Months Ended | |
| Aug. 28, 2014 | Aug. 31, 2014 | Nov. 30, 2013 | |
| Class of Stock [Line Items] | ' | ' | ' |
| Common Stock, Shares Authorized | ' | 5,000,000,000 | 5,000,000,000 |
| Common Stock, Par or Stated Value Per Share | ' | $0.00 | $0.00 |
| Preferred Stock, Shares Authorized | ' | 500,000,000 | 500,000,000 |
| Preferred Stock, Par or Stated Value Per Share | ' | $0.00 | $0.00 |
| Stockholders' Equity Note, Stock Split, Conversion Ratio | 50 | ' | ' |
| Proceeds from Issuance of Common Stock | ' | $40,000 | ' |
| Common Stock [Member] | ' | ' | ' |
| Class of Stock [Line Items] | ' | ' | ' |
| Stock Issued During Period, Shares, New Issues | ' | 20,000,000 | ' |
| Share Price | ' | $0.00 | ' |
| SUBSEQUENT EVENTS (Details Textual) (Subsequent Event [Member], USD $) | 1 Months Ended | 1 Months Ended | 0 Months Ended | ||||||
| Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 16, 2014 | Sep. 16, 2014 | Sep. 16, 2014 | Sep. 16, 2014 | Sep. 30, 2014 | |
| Series A [Member] | Series A [Member] | Series B [Member] | Common Stock [Member] | Common Stock [Member] | Common Stock [Member] | Common Stock [Member] | Warrant [Member] | ||
| Minimum [Member] | Cash [Member] | Debt [Member] | Interest Expense [Member] | ||||||
| Subsequent Event [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
| Stock Repurchased During Period, Shares | ' | ' | ' | ' | 199,995,000 | ' | ' | ' | ' |
| Stock Repurchased During Period, Value | ' | ' | ' | ' | ' | $8,000 | $7,000 | $320 | ' |
| Stock Issued During Period, Shares, Acquisitions | ' | ' | ' | ' | 26,870,132 | ' | ' | ' | ' |
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | 52,631,579 | 1,461,988 | 22,368,421 | ' | ' | ' | ' | ' |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | ' | $0.76 | ' | $0.76 | ' | ' | ' | ' | $0.76 |
| Sale of Stock, Price Per Share | ' | ' | ' | ' | ' | ' | ' | ' | $0.78 |
| Put Notice Terms | '(i) purchase the Minimum Amount by a date identified in the Put Notice that is no earlier than 10 days after and no later than 30 days after the date of the Put Notice (the “Put Date”), or if Capstone has previously exercised the First Warrant to purchase shares in excess of the Minimum Rate, then such lesser amount of Common Stock as would, if purchased as of the applicable Exercise Date, have made Capstone’s purchases of Common Stock pursuant to the First Warrant as of such Exercise Date equal to the Minimum Rate (the “Initial Mandatory Purchase”), and (ii) purchase by a date that is no later than each subsequent Periodic Exercise Date an amount of Common Stock such that as of each such Periodic Exercise Date, Capstone’s cumulative purchases of Common Stock pursuant to the First Warrant through that date has been at a rate that is no less than the Minimum Rate (the “Periodic Mandatory Purchases”). | ' | ' | ' | ' | ' | ' | ' | ' |
| Class of Warrant or Right, Date from which Warrants or Rights Exercisable | ' | 1-Oct-14 | ' | 1-Oct-14 | ' | ' | ' | ' | ' |
